UC Davis Health has been awarded a four-year, $3.9 million contract to provide training and technical assistance to programs in California aimed at identifying and treating people in the early stages of psychosis or a mood disorder.
A new study confirms the low likelihood that coronavirus contamination on hospital surfaces is infectious. The study is the original report on recovering near-complete SARS-CoV-2 genome sequences directly from surface swabs.
The UC Davis MIND Institute is offering a new COVID-19 vaccine clinic for individuals with autism and other neurodevelopmental conditions. The clinic will offer a comfortable experience for families, including sensory support and specially trained staff.
Two School of Medicine faculty received UC Davis Chancellor’s Innovation Awards. David E. Olson received an Innovator of the Year Award and Richard W. Michelmore received an Innovative Community Partner Award.
UCI infectious disease expert Philip Felgner, PhD, is one of seven scholars to win Spain’s prestigious Princess of Asturias Award for Technical and Scientific Research in recognition of their contributions to designing COVID-19 vaccines. “It is a great honor, and I am so happy the jury selected me for this…
A groundbreaking study found that stem cells reduce the amount of virus causing AIDS, boost the body’s antiviral immunity, and restore the gut’s lymphoid follicles damaged by HIV. It provided a roadmap for multi-pronged HIV eradication strategies.
Researchers at UC San Francisco have found that extreme caloric restriction diets alter the microbiome in ways that could help with weight loss but might also result in an increased population of Clostridioides difficile, a pathogenic bacterium that can lead to severe diarrhea and colitis.
